Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |